N-deglycosylation of human complement component C9 reduces its hemolytic activity. 1989

R Kontermann, and E W Rauterberg
Institute of Immunology, University of Heidelberg, F.R.G.

The effect of enzymatic deglycosylation of human complement component C9 on its hemolytic activity was investigated. Treatment of native C9 (Mr 71,000) with glyocpeptidase F (PNGase F) results in a stepwise decrease of the mol. wt. The formation of an Mr 67,000 peptide which is further converted to Mr 63,000 suggests that there are two N-linked carbohydrate chains per C9 polypeptide. Removal of approximately 88% of the N-linked oligosaccharides results in 80% reduction of the hemolytic activity (CH50). The completely N-deglycosylated Mr 63,000 peptide contains a remaining amount of 25% of the total carbohydrates of native C9. These glycans are assumed to be O-linked and predominantly attached to the C9a part of C9. The electrophoretic mobility of C9 is not affected by endoglycosidase F or H treatments revealing that the two N-linked glycans are of the tri- or tetra-antennary complex type. Cleavage of terminal sialic acids from native C9 by neuraminidase results in an Mr 67,000 product with nearly unaltered hemolytic activity. In contrast to other glycoproteins in which deglycosylation remained without major effects on their functional activity, our findings suggest that the N-linked carbohydrates are required for full expression of hemolytic activity of C9.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D003186 Complement C9 A 63-kDa serum glycoprotein encoded by gene C9. Monomeric C9 (mC9) binds the C5b-8 complex to form C5b-9 which catalyzes the polymerization of C9 forming C5b-p9 (MEMBRANE ATTACK COMPLEX) and transmembrane channels leading to lysis of the target cell. Patients with C9 deficiency suffer from recurrent bacterial infections. C9 Complement,Complement 9,Complement Component 9,C9, Complement,Complement, C9,Component 9, Complement
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000581 Amidohydrolases Any member of the class of enzymes that catalyze the cleavage of amide bonds and result in the addition of water to the resulting molecules. Amidases,Amidohydrolase
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D043524 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase An amidohydrolase that removes intact asparagine-linked oligosaccharide chains from glycoproteins. It requires the presence of more than two amino-acid residues in the substrate for activity. This enzyme was previously listed as EC 3.2.2.18. Glycopeptidase,Glycopeptidase A,Glycopeptidase F,Glycopeptide N-glycosidase,N-Glycanase,N-Glycosidase A,N-Glycosidase F,N-Oligosaccharide Glycopeptidase,PNGase A,PNGase F,Peptide N-Glycanase,Peptide N-Glycosidase,Peptide N-glycohydrolase F,Peptide-N(4)-(acetyl-beta-glucosaminyl)Asparagine Amidase,Peptide-N-Glycanase,Glycopeptidase, N-Oligosaccharide,Glycopeptide N glycosidase,N Glycanase,N Glycosidase A,N Glycosidase F,N Oligosaccharide Glycopeptidase,N-Glycanase, Peptide,N-Glycosidase, Peptide,N-glycohydrolase F, Peptide,N-glycosidase, Glycopeptide,Peptide N Glycanase,Peptide N Glycosidase,Peptide N glycohydrolase F

Related Publications

R Kontermann, and E W Rauterberg
September 2015, Asian-Australasian journal of animal sciences,
R Kontermann, and E W Rauterberg
June 1999, Molecular immunology,
R Kontermann, and E W Rauterberg
October 1992, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
R Kontermann, and E W Rauterberg
July 1986, The Journal of biological chemistry,
R Kontermann, and E W Rauterberg
February 1985, The EMBO journal,
R Kontermann, and E W Rauterberg
November 1985, The Journal of biological chemistry,
R Kontermann, and E W Rauterberg
September 1990, Nucleic acids research,
R Kontermann, and E W Rauterberg
November 1983, Journal of immunological methods,
R Kontermann, and E W Rauterberg
December 1986, Clinical endocrinology,
R Kontermann, and E W Rauterberg
October 1983, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!